Added to YB: 2025-11-12
Pitch date: 2025-11-05
FRE.DE [bullish]
Fresenius SE & Co. KGaA
-1.07%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
Market Cap
EUR 26.6B
Pitch Price
EUR 47.15
Price Target
N/A
Dividend
2.23%
EV/EBITDA
11.05
P/E
16.99
EV/Sales
1.61
Sector
Health Care Providers and Services
Category
turnaround
Medtech, telcos and AI fears - Fresenius SE (FRE.DE)
FRE.DE (quick overview): Strong Q results, EBIT & net income beat expectations driven by Kabi's double-digit biopharma/nutrition growth. Helios stable despite seasonal softness. Germany/Spain solid organic growth. Mgmt raised FY EBIT guidance on improved visibility. Turnaround gaining momentum w/ cleaner structure, higher margins, pricing power.
Read full article (2 min)